Article
Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.
The protein journal - 1 Mar 2011
Liu Zhigang, Wang Yong, Brunzelle Joseph, Kovari Iulia A, Kovari Ladislau C
Abstract excerpt
Under drug selection pressure, emerging mutations render HIV-1 protease drug resistant, leading to the therapy failure in anti-HIV treatment. It is known that nine substrate cleavage site peptides bind to wild type (WT) HIV-1 protease in a conserved pattern. However, how the multidrug-resistant (MDR) HIV-1 protease binds to the substrate cleavage site peptides is yet to be determined. MDR769 HIV-1 protease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
